In the present study, we did not investigate whether the CD4/CD8 TIL and FOXP3 levels in the tumor specimens correlated with VEGFR2 expression, and the biological mechanism underlying the increased efficacy of RD after continuous ICI treatment for >180 days remains unresolved. The gene discussed is CD8A; the disease is neoplasm.